The second amendment to the MDR/IVDR standardisation request M/575 has been adopted on 27 May 2024 as “COMMISSION IMPLEMENTING DECISION amending Implementing Decision C(2021) 2406 on a standardisation request to the European Committee for Standardization and the European Committee for Electrotechnical Standardization as regards medical devices in support of Regulation (EU) 2017/745 of the European Parliament and of the Council and in vitro diagnostic medical devices in support of Regulation (EU) 2017/746 of the European Parliament and of the Council, as regards the scope and validity of the request and the deadlines for the joint final report and for the adoption of certain harmonised standards, certain general requirements and the requirements for certain specific standards (C(2024)3371)”.
News & Trends
Procurar
Recentes
- FDA Biosimilar Development – Q&A Guidance: Q&As on Biosimilar Development and the BPCI Act
- NDSG workplan 2026-2028 : Data and AI in medicines regulation
- New guidance on the conduct of clinical trials during public health emergencies
- Nova lei regula ensaios clínicos de medicamentos para uso humano em Portugal
- FDA draft guidance :“New Clinical Investigation Exclusivity: 3-Year Exclusivity for Drug Products – Questions and Answers.”
- webinar INTELIGÊNCIA ARTIFICIAL NA INDÚSTRIA FARMACÊUTICA :IA EM CONTEXTO GxP (Annex 11, 22, EU AI Act , GAMP®)
- GESTÃO da DISPONIBILIDADE do MEDICAMENTO: “Formação muito útil !
- IMDRF Playbook for Medical Device Regulatory Reliance Programs

